المؤلفون: Anna, François, Goyard, Sophie, Lalanne, Ana Ines, Nevo, Fabien, Gransagne, Marion, Souque, Philippe, Louis, Delphine, Gillon, Véronique, Turbiez, Isabelle, Bidard, François-Clement, Gobillion, Aline, Savignoni, Alexia, Guillot-Delost, Maude, Déjardin, François, Dufour, Evelyne, Pêtres, Stéphane, Richard-Le Goff, Odile, Choucha, Zaineb, Helynck, Olivier, Janin, Yves, Louis, Escriou, Nicolas, Charneau, Pierre, Perez, Franck, Rose, Thierry, Lantz, Olivier

المساهمون: Laboratoire commun Pasteur-TheraVectys, Institut Pasteur Paris (IP)-TheraVectys, Biologie Cellulaire des Lymphocytes - Lymphocyte Cell Biology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Curie Paris, Laboratoire d’innovation : vaccins – Innovation lab : vaccines, Institut Pasteur Paris (IP), Virologie Moléculaire et Vaccinologie / Molecular Virology and Vaccinology, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Université Paris-Saclay, Immunité et cancer (U932), Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Plateforme technologique Production et purification de protéines recombinantes – Production and Purification of Recombinant Proteins Technological Platform (PPR), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Chimie et Biocatalyse, Institut Pasteur Paris (IP)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), This work was made possible thanks to the financial support obtained through the URGENCE nouveau coronavirus fundraising campaign of Institut Pasteur and the financial support of the Fondation Total. This study was funded in part by a grant from Fondation de France and by Institut Curie Institutional funding. The luciferin synthesis development has been supported by DARRI (ValoExpress 2016-2018). LuLISA development has been supported by IARP Pasteur-Carnot MI (2019-2020).

المصدر: ISSN: 0014-2980.

مصطلحات موضوعية: COVID-19, ELISA, LuLISA, SARS-CoV-2, bioluminescence, MESH: Adult, MESH: Antibodies, Neutralizing, MESH: Seroepidemiologic Studies, MESH: Time Factors, Viral, MESH: COVID-19, MESH: Female, MESH: Humans, MESH: Immunoglobulin G, MESH: Male, MESH: Pandemics, MESH: Paris, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

Relation: info:eu-repo/semantics/altIdentifier/pmid/33259646; pasteur-02988663; https://pasteur.hal.science/pasteur-02988663; https://pasteur.hal.science/pasteur-02988663v2/document; https://pasteur.hal.science/pasteur-02988663v2/file/Anna_Eur-J-Immunol-2021-51.pdf; PUBMED: 33259646; PUBMEDCENTRAL: PMC7753614

الاتاحة: https://pasteur.hal.science/pasteur-02988663
https://pasteur.hal.science/pasteur-02988663v2/document
https://pasteur.hal.science/pasteur-02988663v2/file/Anna_Eur-J-Immunol-2021-51.pdf
https://doi.org/10.1101/2020.10.25.20219030

المؤلفون: Anna, François, Goyard, Sophie, Lalanne, Ana Ines, Nevo, Fabien, Gransagne, Marion, Souque, Philippe, Louis, Delphine, Gillon, Véronique, Turbiez, Isabelle, Bidard, François‐Clément, Gobillion, Aline, Savignoni, Alexia, Guillot‐Delost, Maude, Dejardin, François, Dufour, Evelyne, Petres, Stéphane, Richard‐Le Goff, Odile, Choucha, Zaineb, Helynck, Olivier, Janin, Yves L., Escriou, Nicolas, Charneau, Pierre, Perez, Franck, Rose, Thierry, Lantz, Olivier

المصدر: European Journal of Immunology ; volume 51, issue 1, page 180-190 ; ISSN 0014-2980 1521-4141

الاتاحة: http://dx.doi.org/10.1002/eji.202049058
https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202049058
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/eji.202049058

المؤلفون: Alice Clément-Zhao, Marie-Laure Tanguy, Paul Cottu, Brigitte De La Lande, Patrick Bontemps, Claire Lemanski, Pierre Baumann, Alexia Savignoni, Christelle Levy, Karine Peignaux, Agnès Reynaud-Bougnoux, Aline Gobillion, Youlia Kirova

المصدر: PLoS ONE, Vol 14, Iss 8, p e0221816 (2019)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1932-6203

URL الوصول: https://doaj.org/article/a32bec6d65d443e996daa9210d42a479

المؤلفون: Pernin, V., Belin, L., Gobillion, A., Cottu, P., Bontemps, P., Lemanski, C., de La Lande, B., Baumann, P., Missohou, F., Levy, C., Peignaux, K., Bougnoux, P., Denis, F., Bollet, M., Fourquet, A., Kirova, Y.

المساهمون: Société Française de Sénologie et de Pathologie Mammaire - SFSPM

المصدر: 35° Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Montpellier, 2013. Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale
https://hal.science/hal-03580372
35° Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Montpellier, 2013. Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale, Nov 2013, Montpellier, France. pp.472

مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

جغرافية الموضوع: Montpellier, France

Relation: hal-03580372; https://hal.science/hal-03580372; https://hal.science/hal-03580372/document; https://hal.science/hal-03580372/file/bitstream_110699.pdf

الاتاحة: https://hal.science/hal-03580372
https://hal.science/hal-03580372/document
https://hal.science/hal-03580372/file/bitstream_110699.pdf

المؤلفون: Jacob, J., Belin, L., Pierga, J.Y., Gobillion, A., Dendale, R., Beuzeboc, P., Campana, F., Fourquet, A., Kirova, Y.M.

المساهمون: Société Française de Sénologie et de Pathologie Mammaire - SFSPM

المصدر: 35° Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Montpellier, 2013. Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale
https://hal.science/hal-03580468
35° Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Montpellier, 2013. Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale, Nov 2013, Montpellier, France. pp.380

مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

جغرافية الموضوع: Montpellier, France

Relation: hal-03580468; https://hal.science/hal-03580468; https://hal.science/hal-03580468/document; https://hal.science/hal-03580468/file/bitstream_110658.pdf

الاتاحة: https://hal.science/hal-03580468
https://hal.science/hal-03580468/document
https://hal.science/hal-03580468/file/bitstream_110658.pdf

المؤلفون: Cao, K.I., Lebas, N., Gerber, S., Levy, C., Le Scodan, R., Bourgier, C., Pierga, J.-Y., Gobillion, A., Savignoni, A., Kirova, Y.M.

المصدر: Annals of Oncology ; volume 26, issue 1, page 89-94 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdu488
https://api.elsevier.com/content/article/PII:S0923753419313304?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419313304?httpAccept=text/plain

المؤلفون: PH Cottu, C. Levy, A Gobillion, K Peignaux, B. De La Lande, A. Clément-Zhao, C. Lemanski, P. Bontemps, M-L Tanguy, A Reynaud-Bougnoux, Y.M. Kirova, P Baumann

المصدر: Cancer Research. 79:P3-12

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Bevacizumab, business.industry, medicine.medical_treatment, Cancer, Common Terminology Criteria for Adverse Events, medicine.disease, Radiation therapy, Clinical trial, Breast cancer, Internal medicine, medicine, Prospective cohort study, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7a301ed8231885fc8b7bcdc1ff3726c6
https://doi.org/10.1158/1538-7445.sabcs18-p3-12-06

المؤلفون: F. Denis, B. De La Lande, P Baumann, C. Lemanski, P. Bontemps, V. Pernin, Paul-Henri Cottu, Lisa Belin, Christine Levy, F. Missohou, A Reynaud-Bougnoux, A Gobillion, Y.M. Kirova, A. Dautruche, K Peignaux

المصدر: Cancer/Radiothérapie. 22:222-228

مصطلحات موضوعية: Adult, 0301 basic medicine, medicine.medical_specialty, Time Factors, Bevacizumab, medicine.medical_treatment, Breast Neoplasms, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Breast cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, Prospective Studies, Prospective cohort study, Aged, business.industry, Common Terminology Criteria for Adverse Events, Middle Aged, medicine.disease, Combined Modality Therapy, Radiation therapy, 030104 developmental biology, Lymphedema, Oncology, 030220 oncology & carcinogenesis, Concomitant, Toxicity, Female, Radiology, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e2161494662959e13c78a4160bd7fb
https://doi.org/10.1016/j.canrad.2017.10.004

المؤلفون: P. Bontemps, K Peignaux, Agnès Reynaud-Bougnoux, Christelle Levy, P Baumann, Marie-Laure Tanguy, Alice Clément-Zhao, Brigitte De La Lande, Paul Cottu, Youlia M. Kirova, Alexia Savignoni, A Gobillion, Claire Lemanski

المصدر: PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0221816 (2019)

مصطلحات موضوعية: Oncology, Adjuvant Chemotherapy, medicine.medical_treatment, Cancer Treatment, Drug research and development, Toxicology, Pathology and Laboratory Medicine, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Clinical trials, Antineoplastic Agents, Immunological, Breast Tumors, Medicine and Health Sciences, Neoplasm Metastasis, Prospective cohort study, Booster Doses, Lymph node, Vaccines, Multidisciplinary, Pharmaceutics, Combined Modality Therapy, Bevacizumab, medicine.anatomical_structure, Lymphedema, Infectious Diseases, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Toxicity, Medicine, Female, Phase II clinical investigation, medicine.drug, Research Article, Clinical Oncology, medicine.medical_specialty, Infectious Disease Control, Science, Radiation Therapy, Surgical and Invasive Medical Procedures, Breast Neoplasms, 03 medical and health sciences, Cancer Chemotherapy, Breast cancer, Drug Therapy, Internal medicine, Breast Cancer, medicine, Chemotherapy, Humans, Neoplasm Staging, Pharmacology, business.industry, Biology and Life Sciences, Cancers and Neoplasms, medicine.disease, Radiation therapy, Research and analysis methods, Radiotherapy, Adjuvant, Clinical Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe69fdd80bc2d6fa767172268cfb364f
http://europepmc.org/articles/PMC6716668

المؤلفون: Y.M. Kirova, PH Cottu, A. Dautruche, C. Lemanski, P. Bontemps, P Baumann, Christine Levy, F. Missohou, A Reynaud-Bougnoux, Alain Fourquet, Lisa Belin, K Peignaux, B. De La Lande, A Gobillion, N Ady Vago, F. Denis

المصدر: Cancer Research. 77:P1-10

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, medicine.medical_treatment, Cancer, Common Terminology Criteria for Adverse Events, medicine.disease, Gastroenterology, Surgery, Radiation therapy, Breast cancer, Oncology, Internal medicine, Concomitant, Toxicity, medicine, Prospective cohort study, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7a9f213df0d07e50d2660d75c83f3c49
https://doi.org/10.1158/1538-7445.sabcs16-p1-10-17

المؤلفون: Anne Vincent-Salomon, J-Y Pierga, Alain Fourquet, J. Jacob, Lisa Belin, A. Gobillion, R. Dendale, François Campana, P. Beuzeboc, Y.M. Kirova

المصدر: Breast Cancer Research and Treatment. 148:345-353

مصطلحات موضوعية: Adult, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Antineoplastic Agents, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Gastroenterology, Loading dose, Immunoenzyme Techniques, Breast cancer, Trastuzumab, Internal medicine, Biomarkers, Tumor, Humans, Medicine, Prospective Studies, Prospective cohort study, Aged, Neoplasm Staging, Univariate analysis, Ejection fraction, business.industry, Carcinoma, Ductal, Breast, Common Terminology Criteria for Adverse Events, Chemoradiotherapy, Middle Aged, Prognosis, medicine.disease, Surgery, Survival Rate, Radiation therapy, Carcinoma, Lobular, Receptors, Estrogen, Oncology, Female, Radiotherapy, Adjuvant, Neoplasm Grading, Neoplasm Recurrence, Local, Receptors, Progesterone, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b19c4e260277d775938d4726d62b66
https://doi.org/10.1007/s10549-014-3166-5

المؤلفون: Christine Levy, Céline Bourgier, H Marsiglia, S. Gerber, Alexia Savignoni, Y.M. Kirova, N. Lebas, R. Le Scodan, A Gobillion, J-Y Pierga, K.I. Cao

المصدر: Cancer Research. 73:P6-11

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Temozolomide, business.industry, medicine.medical_treatment, Phases of clinical research, Cancer, medicine.disease, Surgery, Radiation therapy, Breast cancer, Internal medicine, Concomitant, medicine, Clinical endpoint, Progression-free survival, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::88cf3e8a55380578838b70bd6550a7ec
https://doi.org/10.1158/0008-5472.sabcs13-p6-11-01

المؤلفون: V-E Pernin, Lisa Belin, A Gobillion, C. Lemanski, P. Bontemps, F. Denis, B. De La Lande, Christelle Levy, K Peignaux, P Baumann, Philippe Bougnoux, F. Missohou, PH Cottu, Y.M. Kirova

المصدر: Cancer Research. 73:P5-14

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Cancer, Common Terminology Criteria for Adverse Events, medicine.disease, law.invention, Surgery, Lymphedema, Breast cancer, Randomized controlled trial, law, Internal medicine, medicine, Adjuvant therapy, business, Triple-negative breast cancer, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e41c2c8032abbfdb74f10c1531c03ef6
https://doi.org/10.1158/0008-5472.sabcs13-p5-14-11

المؤلفون: Marc A. Bollet, R. Dendale, François Campana, Alain Fourquet, C. Daveau-Bergerault, Youlia M. Kirova, A. Gobillion, J. Jacob, Lisa Belin, P. Beuzeboc

المصدر: Cancer/Radiothérapie. 17:183-190

مصطلحات موضوعية: Gynecology, medicine.medical_specialty, Oncology, business.industry, Medicine, Radiology, Nuclear Medicine and imaging, business, Skin pathology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ccb86b9e4348c308f62d84fc9d3071a1
https://doi.org/10.1016/j.canrad.2012.12.006

المؤلفون: Clément-Zhao, Alice, Tanguy, Marie-Laure, Cottu, Paul, De La Lande, Brigitte, Bontemps, Patrick, Lemanski, Claire, Baumann, Pierre, Savignoni, Alexia, Levy, Christelle, Peignaux, Karine, Reynaud-Bougnoux, Agnès, Gobillion, Aline, Kirova, Youlia

المصدر: PLoS ONE; 8/30/2019, Vol. 14 Issue 8, p1-11, 11p

مصطلحات موضوعية: BREAST cancer, ADJUVANT treatment of cancer, RADIOTHERAPY, PROGRESSION-free survival, LYMPH nodes

المؤلفون: Pernin, V, Belin, L, Cottu, P, Bontemps, P, Lemanski, C, De La Lande, B, Baumann, P, Missohou, F, Levy, C, Peignaux, K, Reynaud-Bougnoux, A, Denis, F, Gobillion, A, Bollet, M, Vago, N A, Dendale, R, Campana, F, Fourquet, A, Kirova, Y M

المصدر: The British Journal of Radiology ; volume 88, issue 1048, page 20140800 ; ISSN 0007-1285 1748-880X

مصطلحات موضوعية: Radiology, Nuclear Medicine and imaging, General Medicine

الاتاحة: http://dx.doi.org/10.1259/bjr.20140800
http://www.birpublications.org/doi/pdf/10.1259/bjr.20140800

المؤلفون: Cao, K.I., Lebas, N., Gerber, S., Levy, C., Fourquet, A., Campana, F., Le Scodan, R., De La Lande, B., Bourgier, C., Pierga, J., Gobillion, A., Savignoni, A., Kirova, Y.M.

المصدر: International Journal of Radiation Oncology*Biology*Physics ; volume 90, issue 1, page S163 ; ISSN 0360-3016

الاتاحة: http://dx.doi.org/10.1016/j.ijrobp.2014.05.658
https://api.elsevier.com/content/article/PII:S0360301614013091?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0360301614013091?httpAccept=text/plain

المؤلفون: Jacob, J., Belin, L., Pierga, J., Gobillion, A., Dendale, R., Beuzeboc, P., Campana, F., Fourquet, A., Kirova, Y.

المصدر: Cancer/Radiothérapie ; volume 17, issue 5-6, page 612 ; ISSN 1278-3218

الاتاحة: http://dx.doi.org/10.1016/j.canrad.2013.07.076
https://api.elsevier.com/content/article/PII:S1278321813002151?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1278321813002151?httpAccept=text/plain

المؤلفون: Jacob, J., Belin, L., Gobillion, A., Daveau-Bergerault, C., Dendale, R., Beuzeboc, P., Campana, F., Bollet, M., Fourquet, A., Kirova, Y.

المصدر: Cancer/Radiothérapie ; volume 16, issue 5-6, page 528 ; ISSN 1278-3218

الاتاحة: http://dx.doi.org/10.1016/j.canrad.2012.07.038
https://api.elsevier.com/content/article/PII:S1278321812001783?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1278321812001783?httpAccept=text/plain

المؤلفون: J, Jacob, L, Belin, A, Gobillion, C, Daveau-Bergerault, R, Dendale, P, Beuzeboc, F, Campana, M-A, Bollet, A, Fourquet, Y M, Kirova

المصدر: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 17(3)

مصطلحات موضوعية: Adult, Aged, 80 and over, Carcinoma, Ductal, Breast, Pain, Antineoplastic Agents, Breast Neoplasms, Stroke Volume, Chemoradiotherapy, Middle Aged, Trastuzumab, Antibodies, Monoclonal, Humanized, Mastectomy, Segmental, Fibrosis, Esophagitis, Humans, Female, Lymphedema, Prospective Studies, Telangiectasis, Radiodermatitis, Mastectomy, Aged, Skin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::98e4e95dc21518d451a02aaf85c06826
https://pubmed.ncbi.nlm.nih.gov/23499212